BBIO - BridgeBio Pharma - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BBIO is currently covered by 12 analysts with an average price target of $42.55. This is a potential upside of $14.94 (54.11%) from yesterday's end of day stock price of $27.61.

BridgeBio Pharma's activity chart (see below) currently has 75 price targets and 88 ratings on display. The stock rating distribution of BBIO is 97.44% BUY and 2.56% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 66.82% with an average time for these price targets to be met of 221.57 days.

Highest price target for BBIO is $70, Lowest price target is $24, average price target is $42.55.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 05-Jun-2024. First documented stock forecast 22-Jul-2019.

Currently out of the existing stock ratings of BBIO, 38 are a BUY (97.44%), 1 are a HOLD (2.56%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

43

$15.39 (55.74%)

43

14 days ago

6/14 (42.86%)

$15 (53.57%)

327

Buy

47

$19.39 (70.23%)

30

22 days ago

2/4 (50%)

$19.18 (68.94%)

334

Buy

70

$42.39 (153.53%)

60

22 days ago

1/5 (20%)

$42.18 (151.62%)

244

Buy

46

$18.39 (66.61%)

42

3 months 27 days ago

1/2 (50%)

$12 (35.29%)

50

Buy

60

$32.39 (117.31%)

60

9 months 22 days ago

6/11 (54.55%)

$31.33 (109.28%)

240

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BBIO (BridgeBio Pharma) average time for price targets to be met?

On average it took 221.57 days on average for the stock forecasts to be realized with a an average price target met ratio 66.82

Which analyst has the current highest performing score on BBIO (BridgeBio Pharma) with a proven track record?

TYLER VAN BUREN

Which analyst has the most public recommendations on BBIO (BridgeBio Pharma)?

Tyler Van Buren works at TD COWEN and has 3 price targets and 2 ratings on BBIO

Which analyst is the currently most bullish on BBIO (BridgeBio Pharma)?

Josh Schimmer with highest potential upside - $42.39

Which analyst is the currently most reserved on BBIO (BridgeBio Pharma)?

Geoff Meacham with lowest potential downside - -$12.61

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?